Compounds > isoconazole

isoconazole and bay h 4502

isoconazole has been researched along with bay h 4502 in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19904 (57.14)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's1 (14.29)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Brodie, AM; Clement, OO; Freeman, CM; Handratta, VD; Hartmann, RW; Njar, VC; Vasaitis, TS1
Bron, S; Chambon, M; Colau, D; Majjigapu, SR; Michielin, O; Pilotte, L; Röhrig, UF; Turcatti, G; Van den Eynde, BJ; Vogel, P; Zoete, V1
Bozkurt, M; Gürer, MA; Kuştimur, S1
Frosch, PJ; Raulin, C1
Abbott, AB; Odds, FC; Webster, CE1
Qadripur, SA1
Chmielewski, MK; Cielecka-Piontek, J; Dettlaff, K; Drabińska, B; Kossakowski, K; Kujawski, J; Ratajczak, T1

Other Studies

7 other study(ies) available for isoconazole and bay h 4502

ArticleYear
Three dimensional pharmacophore modeling of human CYP17 inhibitors. Potential agents for prostate cancer therapy.
    Journal of medicinal chemistry, 2003, Jun-05, Volume: 46, Issue:12

    Topics: Algorithms; Antineoplastic Agents; Azoles; Binding Sites; Enzyme Inhibitors; Humans; Hydrogen Bonding; Male; Models, Molecular; Prostatic Neoplasms; Protein Binding; Quantitative Structure-Activity Relationship; Steroid 17-alpha-Hydroxylase; Steroids

2003
Detailed analysis and follow-up studies of a high-throughput screening for indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors.
    European journal of medicinal chemistry, 2014, Sep-12, Volume: 84

    Topics: Animals; Antifungal Agents; Dose-Response Relationship, Drug; Enzyme Inhibitors; High-Throughput Screening Assays; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Mice; Molecular Dynamics Simulation; Molecular Structure; Structure-Activity Relationship

2014
[In vitro susceptibility of dermatophyte strains to imidazole derivatives].
    Mikrobiyoloji bulteni, 1989, Volume: 23, Issue:1

    Topics: Antifungal Agents; Arthrodermataceae; Dermatomycoses; Humans; Imidazoles; Miconazole

1989
Contact allergy to imidazole antimycotics.
    Contact dermatitis, 1988, Volume: 18, Issue:2

    Topics: Adult; Aged; Antifungal Agents; Chemical Phenomena; Chemistry; Clotrimazole; Drug Eruptions; Econazole; Female; Humans; Imidazoles; Male; Miconazole; Middle Aged; Prospective Studies

1988
Antifungal relative inhibition factors: BAY l-9139, bifonazole, butoconazole, isoconazole, itraconazole (R 51211), oxiconazole, Ro 14-4767/002, sulconazole, terconazole and vibunazole (BAY n-7133) compared in vitro with nine established antifungal agents.
    The Journal of antimicrobial chemotherapy, 1984, Volume: 14, Issue:2

    Topics: Antifungal Agents; Aspergillus; Candida; Clotrimazole; Econazole; Imidazoles; In Vitro Techniques; Itraconazole; Ketoconazole; Miconazole; Morpholines; Triazoles

1984
[Antimycotic therapy. 2. Antimycotic chemotherapeutic agents: imidazole derivatives, tolciclate, haloprogin, ciclopiroxolamin].
    Fortschritte der Medizin, 1983, Mar-10, Volume: 101, Issue:9

    Topics: Antifungal Agents; Chemical Phenomena; Chemistry; Ciclopirox; Clotrimazole; Dermatomycoses; Econazole; Humans; Imidazoles; Ketoconazole; Miconazole; Phenyl Ethers; Piperazines; Pyridones; Thiocarbamates

1983
Structural and Spectroscopic Properties of Isoconazole and Bifonazole-Experimental and Theoretical Studies.
    International journal of molecular sciences, 2022, Dec-28, Volume: 24, Issue:1

    Topics: Models, Molecular; Quantum Theory; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis, Raman; Thermodynamics; Vibration

2022